ARCHIVES

Movement To Resolve Patient Care Reimbursement Problems Gains Momentum; NCI Report Adds Fuel

This article is from The Cancer Letter archive.

Vol. 15 No. 11 | March 17, 1989

Download PDF Visit The Full Archive

Related Articles

In Brief Yale Cancer Center Begins Reorganization, Names New Deputy Director, Prevention Chief

January 6, 1995

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002

Doroshow: NCI Leaves It Up to Groups To Make Their Own Merger Deals

February 11, 2011

Improved Therapies For Cervical Cancer Said To Show Promise In Clinical Trials

March 26, 2004

Nevins Retracts Key Paper By Duke Group, Raising Question Of Harm To Patients

October 29, 2010